-
1
-
-
0036276786
-
Metabolism of the analgesic drug ULTRAM (tramadol hydrochloride) in humans: API-MS and MS/MS characterization of metabolites
-
Wu WN, McKown LA, Liao S. Metabolism of the analgesic drug ULTRAM (tramadol hydrochloride) in humans: API-MS and MS/MS characterization of metabolites. Xenobiotica 2002; 32 (5): 411-425.
-
(2002)
Xenobiotica
, vol.32
, Issue.5
, pp. 411-425
-
-
Wu, W.N.1
Mckown, L.A.2
Liao, S.3
-
2
-
-
0026649268
-
The metabolism of tramadol by human liver microsomes
-
Paar WD, Frankus P, Dengler HJ. The metabolism of tramadol by human liver microsomes. Clin Investig 1992; 70 (8): 708-710.
-
(1992)
Clin Investig
, vol.70
, Issue.8
, pp. 708-710
-
-
Paar, W.D.1
Frankus, P.2
Dengler, H.J.3
-
3
-
-
30844456020
-
CYP2D6 polymorphism, tramadol pharmacokinetics and pupillary response
-
author reply 77-78
-
Slanar O, Nobilis M, Kvetina J, Idle JR, Perlik F. CYP2D6 polymorphism, tramadol pharmacokinetics and pupillary response. Eur J Clin Pharmacol 2006; 62 (1): 75-76; author reply 77-78.
-
(2006)
Eur J Clin Pharmacol
, vol.62
, Issue.1
, pp. 75-76
-
-
Slanar, O.1
Nobilis, M.2
Kvetina, J.3
Idle, J.R.4
Perlik, F.5
-
4
-
-
67049145399
-
Enatiomeric determination of tramadol and O-desmethyltramadol in human urine by gas chromatography-mass spectrometry
-
Chytil L, Sticha M, Matouskova O, Perlik F, Slanar O. Enatiomeric determination of tramadol and O-desmethyltramadol in human urine by gas chromatography-mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2009; 877 (20-21): 1937-1942.
-
(2009)
J Chromatogr B Analyt Technol Biomed Life Sci
, vol.877
, Issue.20-21
, pp. 1937-1942
-
-
Chytil, L.1
Sticha, M.2
Matouskova, O.3
Perlik, F.4
Slanar, O.5
-
5
-
-
74049104150
-
Enantiomeric determination of tramadol and O-desmethyltramadol in human plasma by fast liquid chromatographic technique coupled with mass spectrometric detection
-
Chytil L, Matouskova O, Cerna O, Pokorna P, Vobruba V, Perlik F, Slanar O. Enantiomeric determination of tramadol and O-desmethyltramadol in human plasma by fast liquid chromatographic technique coupled with mass spectrometric detection. J Chromatogr B Anlyt Technol Biomed Life Sci 2010; 878 (3-4): 481-486.
-
(2010)
J Chromatogr B Anlyt Technol Biomed Life Sci
, vol.878
, Issue.3-4
, pp. 481-486
-
-
Chytil, L.1
Matouskova, O.2
Cerna, O.3
Pokorna, P.4
Vobruba, V.5
Perlik, F.6
Slanar, O.7
-
6
-
-
34250872182
-
Impact of CYP2D6 genetic polymorphism on tramadol pharmacokinetics and pharmacodynamics
-
Gan SH, Ismail R, Wan Adnan WA, Zulmi W. Impact of CYP2D6 genetic polymorphism on tramadol pharmacokinetics and pharmacodynamics. Mol Diagn Ther 2007; 11 (3): 171-181.
-
(2007)
Mol Diagn Ther
, vol.11
, Issue.3
, pp. 171-181
-
-
Gan, S.H.1
Ismail, R.2
Adnan, W.A.W.3
Zulmi, W.4
-
7
-
-
0344081910
-
A rapid and simple CYP2D6 genotyping assay - case study with the analgetic tramadol
-
Borlak J, Hermann R, Erb K, Thum T. A rapid and simple CYP2D6 genotyping assay - case study with the analgetic tramadol. Metabolism 2003; 52 (11): 1439-1443.
-
(2003)
Metabolism
, vol.52
, Issue.11
, pp. 1439-1443
-
-
Borlak, J.1
Hermann, R.2
Erb, K.3
Thum, T.4
-
8
-
-
33947103056
-
Pharmacokinetics of tramadol is affected by MDR1 polymorphism C3435T
-
Slanar O, Nobilis M, Kvetina J, Matouskova O, Idle JR, Perlik F. Pharmacokinetics of tramadol is affected by MDR1 polymorphism C3435T. Eur J Clin Pharmacol 2007; 63 (4): 419-421.
-
(2007)
Eur J Clin Pharmacol
, vol.63
, Issue.4
, pp. 419-421
-
-
Slanar, O.1
Nobilis, M.2
Kvetina, J.3
Matouskova, O.4
Idle, J.R.5
Perlik, F.6
-
9
-
-
0033901486
-
Affinity, potency and efficacy of tramadol and its metabolites at the cloned human mu-opioid receptor
-
Gillen C, Haurand M, Kobelt DJ, Wnendt S. Affinity, potency and efficacy of tramadol and its metabolites at the cloned human mu-opioid receptor. Naunyn Schmiedebergs Arch Pharmacol 2000; 362 (2): 116-121.
-
(2000)
Naunyn Schmiedebergs Arch Pharmacol
, vol.362
, Issue.2
, pp. 116-121
-
-
Gillen, C.1
Haurand, M.2
Kobelt, D.J.3
Wnendt, S.4
-
10
-
-
0027429714
-
Complementary and synergistic antinociceptive interaction between the enantiomers of tramadol
-
Raffa RB, Friderichs E, Reimann W, Shank RP, Codd EE, Vaught JL, Jacoby HI, Selve N. Complementary and synergistic antinociceptive interaction between the enantiomers of tramadol. J Pharmacol Exp Ther 1993; 267 (1): 331-340.
-
(1993)
J Pharmacol Exp Ther
, vol.267
, Issue.1
, pp. 331-340
-
-
Raffa, R.B.1
Friderichs, E.2
Reimann, W.3
Shank, R.P.4
Codd, E.E.5
Vaught, J.L.6
Jacoby, H.I.7
Selve, N.8
-
11
-
-
0141626841
-
Impact of CYP2D6 genotype on postoperative tramadol analgesia
-
Stamer UM, Lehnen K, Hothker F, Bayerer B, Wolf S, Hoeft A, Stuber F. Impact of CYP2D6 genotype on postoperative tramadol analgesia. Pain 2003; 105 (1-2): 231-238.
-
(2003)
Pain
, vol.105
, Issue.1-2
, pp. 231-238
-
-
Stamer, U.M.1
Lehnen, K.2
Hothker, F.3
Bayerer, B.4
Wolf, S.5
Hoeft, A.6
Stuber, F.7
-
12
-
-
0030471120
-
The hypoalgesic effect of tramadol in relation to CYP2D6
-
Poulsen L, Arendt-Nielsen L, Brosen K, Sindrup SH. The hypoalgesic effect of tramadol in relation to CYP2D6. Clin Pharmacol Ther 1996; 60 (6): 636-644.
-
(1996)
Clin Pharmacol Ther
, vol.60
, Issue.6
, pp. 636-644
-
-
Poulsen, L.1
Arendt-nielsen, L.2
Brosen, K.3
Sindrup, S.H.4
-
13
-
-
70450240778
-
Escitalopram is a weak inhibitor of the CYP2D6-catalyzed O-demethylation of (+)-tramadol but does not reduce the hypoalgesic effect in experimental pain
-
Noehr-Jensen L, Zwisler ST, Larsen F, Sindrup SH, Damkier P, Brosen K. Escitalopram is a weak inhibitor of the CYP2D6-catalyzed O-demethylation of (+)-tramadol but does not reduce the hypoalgesic effect in experimental pain. Clin Pharmacol Ther 2009; 86 (6): 626-633.
-
(2009)
Clin Pharmacol Ther
, vol.86
, Issue.6
, pp. 626-633
-
-
Noehr-jensen, L.1
Zwisler, S.T.2
Larsen, F.3
Sindrup, S.H.4
Damkier, P.5
Brosen, K.6
-
14
-
-
29844453632
-
The analgesic effect of tramadol after intravenous injection in healthy volunteers in relation to CYP2D6
-
Enggaard TP, Poulsen L, Arendt-Nielsen L, Brosen K, Ossig J, Sindrup SH. The analgesic effect of tramadol after intravenous injection in healthy volunteers in relation to CYP2D6. Anesth Analg 2006; 102 (1): 146-150.
-
(2006)
Anesth Analg
, vol.102
, Issue.1
, pp. 146-150
-
-
Enggaard, T.P.1
Poulsen, L.2
Arendt-nielsen, L.3
Brosen, K.4
Ossig, J.5
Sindrup, S.H.6
-
15
-
-
38549101363
-
Frequency of single nucleotide polymorphisms of CYP2D6 in the Czech population
-
Buzkova H, Pechandova K, Slanar O, Perlik F. Frequency of single nucleotide polymorphisms of CYP2D6 in the Czech population. Cell Biochem Funct 2008; 26 (1): 76-81.
-
(2008)
Cell Biochem Funct
, vol.26
, Issue.1
, pp. 76-81
-
-
Buzkova, H.1
Pechandova, K.2
Slanar, O.3
Perlik, F.4
-
16
-
-
33845902244
-
Polymorphisms of the MDR1 gene in the Czech population
-
Pechandova K, Buzkova H, Slanar O, Perlik F. Polymorphisms of the MDR1 gene in the Czech population. Folia Biol (Praha) 2006; 52 (6): 184-189.
-
(2006)
Folia Biol (Praha)
, vol.52
, Issue.6
, pp. 184-189
-
-
Pechandova, K.1
Buzkova, H.2
Slanar, O.3
Perlik, F.4
-
17
-
-
85056031934
-
Post-operative pain after knee arthroscopy and related factors
-
Drosos GI, Stavropoulos NI, Katsis A, Kesidis K, Kazakos K, Verettas DA. Post-operative pain after knee arthroscopy and related factors. Open Orthop J 2008; 2: 110-114.
-
(2008)
Open Orthop J
, vol.2
, pp. 110-114
-
-
Drosos, G.I.1
Stavropoulos, N.I.2
Katsis, A.3
Kesidis, K.4
Kazakos, K.5
Verettas, D.A.6
-
18
-
-
32944469959
-
G2677T and C3435T genotype and haplotype are associated with hepatic ABCB1 (MDR1) expression
-
Song P, Lamba JK, Zhang L, Schuetz E, Shukla N, Meibohm B, Yates CR. G2677T and C3435T genotype and haplotype are associated with hepatic ABCB1 (MDR1) expression. J Clin Pharmacol 2006; 46 (3): 373-379.
-
(2006)
J Clin Pharmacol
, vol.46
, Issue.3
, pp. 373-379
-
-
Song, P.1
Lamba, J.K.2
Zhang, L.3
Schuetz, E.4
Shukla, N.5
Meibohm, B.6
Yates, C.R.7
|